Finally, here is a link to a recent news release from Miraculins, highlighting the fact that Alere has chosen to renew their final 6-month option period for testing Miraculins biomarkers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.